Piper Sandler Assumes Aclaris Therapeutis (ACRS) at Overweight, PT $6
Tweet Send to a Friend
Piper Sandler analyst Biren Amin assumes coverage on Aclaris Therapeutis ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
